Reviews Lamivudine


No reviews yet.

Epivir Drug Description
EPIVIR
(lamivudine) Tablets and Oral Solution

WARNING: RISK OF LACTIC ACIDOSIS, EXACERBATIONS OF HEPATITIS B IN I , CO-INFECTED
PATIENTS UPON DISCONTINUATION OF EPIVIR®, DIFFERENT FORMULATIONS OF EPIVIR.
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination, including lamivudine and other antiretrovirals. Suspend treatment
if clinical or laboratory findings suggestive of lactic acidosis or pronounced
hepatotoxicity occur [see WARNINGS and PRECAUTIONS].
Severe acute exacerbations of hepatitis B have been reported in patients
who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued EPIVIR. Hepatic function should be monitored
closely with both clinical and laboratory follow-up for at least several months
in patients who discontinue EPIVIR and are co-infected with HIV-1 and HBV.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS and PRECAUTIONS].
EPIVIR Tablets and Oral Solution (used to treat HIV-1 infection) contain
a higher dose of the active ingredient (lamivudine) than EPIVIR-HBV® Tablets
and Oral Solution (used to treat chronic HBV infection). Patients with HIV-1
infection should receive only dosage forms appropriate for treatment of HIV-1
[see WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of lamivudine (Epivir, Epivir HBV)?

Stop using lamivudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:

liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in...
Read All Potential Side Effects for Epivir »




EPIVIR (also known as 3TC) is a brand name for lamivudine, a synthetic nucleoside
analogue with activity against HIV-1 and HBV. The chemical name of lamivudine
is (2R,cis)-4- amino-l-(2-hydroxymethyl-l,3-oxathiolan-5-yl)-(lH)-pyrimidin-2-one.
Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine
has, also been referred to as (-)2',3'- dideoxy, 3'-thiacytidine. It has a molecular
formula of C8H11N3O3S and a molecular
weight of 229.3. It has the following structural formula:







Lamivudine is a white to off-white crystalline solid with a solubility of approximately 70 mg/mL in water at 20°C.
EPIVIR Tablets are for oral administration. Each scoredl50-mg film-coated tablet contains 150 mg of lamivudine and the inactive ingredients hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
Each 300-mg film-coated tablet contains 300 mg of lamivudine and the inactive ingredients black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
EPIVIR Oral Solution is for oral administration. One, milliliter (1 mL) of
EPIVIR Oral Solution contains 10 mg of lamivudine (10 mg/mL) in an aqueous solution
and the inactive ingredients artificial strawberry and banana flavors, citric
acid (anhydrous), methylparaben, propylene glycol, propylparaben, sodium citrate
(dihydrate), and sucrose (200 mg).Last reviewed on RxList: 3/4/2008




Epivir Drug Description
EPIVIR
(lamivudine) Tablets and Oral Solution

WARNING: RISK OF LACTIC ACIDOSIS, EXACERBATIONS OF HEPATITIS B IN I , CO-INFECTED
PATIENTS UPON DISCONTINUATION OF EPIVIR®, DIFFERENT FORMULATIONS OF EPIVIR.
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination, including lamivudine and other antiretrovirals. Suspend treatment
if clinical or laboratory findings suggestive of lactic acidosis or pronounced
hepatotoxicity occur [see WARNINGS and PRECAUTIONS].
Severe acute exacerbations of hepatitis B have been reported in patients
who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued EPIVIR. Hepatic function should be monitored
closely with both clinical and laboratory follow-up for at least several months
in patients who discontinue EPIVIR and are co-infected with HIV-1 and HBV.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS and PRECAUTIONS].
EPIVIR Tablets and Oral Solution (used to treat HIV-1 infection) contain
a higher dose of the active ingredient (lamivudine) than EPIVIR-HBV® Tablets
and Oral Solution (used to treat chronic HBV infection). Patients with HIV-1
infection should receive only dosage forms appropriate for treatment of HIV-1
[see WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of lamivudine (Epivir, Epivir HBV)?

Stop using lamivudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:

liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in...
Read All Potential Side Effects for Epivir »




EPIVIR (also known as 3TC) is a brand name for lamivudine, a synthetic nucleoside
analogue with activity against HIV-1 and HBV. The chemical name of lamivudine
is (2R,cis)-4- amino-l-(2-hydroxymethyl-l,3-oxathiolan-5-yl)-(lH)-pyrimidin-2-one.
Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine
has, also been referred to as (-)2',3'- dideoxy, 3'-thiacytidine. It has a molecular
formula of C8H11N3O3S and a molecular
weight of 229.3. It has the following structural formula:







Lamivudine is a white to off-white crystalline solid with a solubility of approximately 70 mg/mL in water at 20°C.
EPIVIR Tablets are for oral administration. Each scoredl50-mg film-coated tablet contains 150 mg of lamivudine and the inactive ingredients hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
Each 300-mg film-coated tablet contains 300 mg of lamivudine and the inactive ingredients black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
EPIVIR Oral Solution is for oral administration. One, milliliter (1 mL) of
EPIVIR Oral Solution contains 10 mg of lamivudine (10 mg/mL) in an aqueous solution
and the inactive ingredients artificial strawberry and banana flavors, citric
acid (anhydrous), methylparaben, propylene glycol, propylparaben, sodium citrate
(dihydrate), and sucrose (200 mg).Last reviewed on RxList: 3/4/2008




Epivir Drug Description
EPIVIR
(lamivudine) Tablets and Oral Solution

WARNING: RISK OF LACTIC ACIDOSIS, EXACERBATIONS OF HEPATITIS B IN I , CO-INFECTED
PATIENTS UPON DISCONTINUATION OF EPIVIR®, DIFFERENT FORMULATIONS OF EPIVIR.
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination, including lamivudine and other antiretrovirals. Suspend treatment
if clinical or laboratory findings suggestive of lactic acidosis or pronounced
hepatotoxicity occur [see WARNINGS and PRECAUTIONS].
Severe acute exacerbations of hepatitis B have been reported in patients
who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued EPIVIR. Hepatic function should be monitored
closely with both clinical and laboratory follow-up for at least several months
in patients who discontinue EPIVIR and are co-infected with HIV-1 and HBV.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS and PRECAUTIONS].
EPIVIR Tablets and Oral Solution (used to treat HIV-1 infection) contain
a higher dose of the active ingredient (lamivudine) than EPIVIR-HBV® Tablets
and Oral Solution (used to treat chronic HBV infection). Patients with HIV-1
infection should receive only dosage forms appropriate for treatment of HIV-1
[see WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of lamivudine (Epivir, Epivir HBV)?

Stop using lamivudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:

liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in...
Read All Potential Side Effects for Epivir »




EPIVIR (also known as 3TC) is a brand name for lamivudine, a synthetic nucleoside
analogue with activity against HIV-1 and HBV. The chemical name of lamivudine
is (2R,cis)-4- amino-l-(2-hydroxymethyl-l,3-oxathiolan-5-yl)-(lH)-pyrimidin-2-one.
Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine
has, also been referred to as (-)2',3'- dideoxy, 3'-thiacytidine. It has a molecular
formula of C8H11N3O3S and a molecular
weight of 229.3. It has the following structural formula:







Lamivudine is a white to off-white crystalline solid with a solubility of approximately 70 mg/mL in water at 20°C.
EPIVIR Tablets are for oral administration. Each scoredl50-mg film-coated tablet contains 150 mg of lamivudine and the inactive ingredients hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
Each 300-mg film-coated tablet contains 300 mg of lamivudine and the inactive ingredients black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
EPIVIR Oral Solution is for oral administration. One, milliliter (1 mL) of
EPIVIR Oral Solution contains 10 mg of lamivudine (10 mg/mL) in an aqueous solution
and the inactive ingredients artificial strawberry and banana flavors, citric
acid (anhydrous), methylparaben, propylene glycol, propylparaben, sodium citrate
(dihydrate), and sucrose (200 mg).Last reviewed on RxList: 3/4/2008




Epivir Drug Description
EPIVIR
(lamivudine) Tablets and Oral Solution

WARNING: RISK OF LACTIC ACIDOSIS, EXACERBATIONS OF HEPATITIS B IN I , CO-INFECTED
PATIENTS UPON DISCONTINUATION OF EPIVIR®, DIFFERENT FORMULATIONS OF EPIVIR.
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination, including lamivudine and other antiretrovirals. Suspend treatment
if clinical or laboratory findings suggestive of lactic acidosis or pronounced
hepatotoxicity occur [see WARNINGS and PRECAUTIONS].
Severe acute exacerbations of hepatitis B have been reported in patients
who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued EPIVIR. Hepatic function should be monitored
closely with both clinical and laboratory follow-up for at least several months
in patients who discontinue EPIVIR and are co-infected with HIV-1 and HBV.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS and PRECAUTIONS].
EPIVIR Tablets and Oral Solution (used to treat HIV-1 infection) contain
a higher dose of the active ingredient (lamivudine) than EPIVIR-HBV® Tablets
and Oral Solution (used to treat chronic HBV infection). Patients with HIV-1
infection should receive only dosage forms appropriate for treatment of HIV-1
[see WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of lamivudine (Epivir, Epivir HBV)?

Stop using lamivudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:

liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in...
Read All Potential Side Effects for Epivir »




EPIVIR (also known as 3TC) is a brand name for lamivudine, a synthetic nucleoside
analogue with activity against HIV-1 and HBV. The chemical name of lamivudine
is (2R,cis)-4- amino-l-(2-hydroxymethyl-l,3-oxathiolan-5-yl)-(lH)-pyrimidin-2-one.
Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine
has, also been referred to as (-)2',3'- dideoxy, 3'-thiacytidine. It has a molecular
formula of C8H11N3O3S and a molecular
weight of 229.3. It has the following structural formula:







Lamivudine is a white to off-white crystalline solid with a solubility of approximately 70 mg/mL in water at 20°C.
EPIVIR Tablets are for oral administration. Each scoredl50-mg film-coated tablet contains 150 mg of lamivudine and the inactive ingredients hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
Each 300-mg film-coated tablet contains 300 mg of lamivudine and the inactive ingredients black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
EPIVIR Oral Solution is for oral administration. One, milliliter (1 mL) of
EPIVIR Oral Solution contains 10 mg of lamivudine (10 mg/mL) in an aqueous solution
and the inactive ingredients artificial strawberry and banana flavors, citric
acid (anhydrous), methylparaben, propylene glycol, propylparaben, sodium citrate
(dihydrate), and sucrose (200 mg).Last reviewed on RxList: 3/4/2008




Epivir Drug Description
EPIVIR
(lamivudine) Tablets and Oral Solution

WARNING: RISK OF LACTIC ACIDOSIS, EXACERBATIONS OF HEPATITIS B IN I , CO-INFECTED
PATIENTS UPON DISCONTINUATION OF EPIVIR®, DIFFERENT FORMULATIONS OF EPIVIR.
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination, including lamivudine and other antiretrovirals. Suspend treatment
if clinical or laboratory findings suggestive of lactic acidosis or pronounced
hepatotoxicity occur [see WARNINGS and PRECAUTIONS].
Severe acute exacerbations of hepatitis B have been reported in patients
who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued EPIVIR. Hepatic function should be monitored
closely with both clinical and laboratory follow-up for at least several months
in patients who discontinue EPIVIR and are co-infected with HIV-1 and HBV.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS and PRECAUTIONS].
EPIVIR Tablets and Oral Solution (used to treat HIV-1 infection) contain
a higher dose of the active ingredient (lamivudine) than EPIVIR-HBV® Tablets
and Oral Solution (used to treat chronic HBV infection). Patients with HIV-1
infection should receive only dosage forms appropriate for treatment of HIV-1
[see WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of lamivudine (Epivir, Epivir HBV)?

Stop using lamivudine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:

liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in...
Read All Potential Side Effects for Epivir »




EPIVIR (also known as 3TC) is a brand name for lamivudine, a synthetic nucleoside
analogue with activity against HIV-1 and HBV. The chemical name of lamivudine
is (2R,cis)-4- amino-l-(2-hydroxymethyl-l,3-oxathiolan-5-yl)-(lH)-pyrimidin-2-one.
Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine
has, also been referred to as (-)2',3'- dideoxy, 3'-thiacytidine. It has a molecular
formula of C8H11N3O3S and a molecular
weight of 229.3. It has the following structural formula:







Lamivudine is a white to off-white crystalline solid with a solubility of approximately 70 mg/mL in water at 20°C.
EPIVIR Tablets are for oral administration. Each scoredl50-mg film-coated tablet contains 150 mg of lamivudine and the inactive ingredients hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
Each 300-mg film-coated tablet contains 300 mg of lamivudine and the inactive ingredients black iron oxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, and titanium dioxide.
EPIVIR Oral Solution is for oral administration. One, milliliter (1 mL) of
EPIVIR Oral Solution contains 10 mg of lamivudine (10 mg/mL) in an aqueous solution
and the inactive ingredients artificial strawberry and banana flavors, citric
acid (anhydrous), methylparaben, propylene glycol, propylparaben, sodium citrate
(dihydrate), and sucrose (200 mg).Last reviewed on RxList: 3/4/2008





Other reviews about Lamivudine on wordpress

ARTICLE - A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-2b and Lamivudine with Lamivudine Alone
  by JOC
Source: Ann Intern Med 15 Feb 2005 Vol 142 N.4 P.240-250 Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; Vincent Wai-Sun Wong, MBChB; Choong-Tsek […]


Leading article - Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy
  by JOC
Source: Journal of Antimicrobial Chemotherapy 2005 55(6):828-831 Ramazan Idilman* Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey * Fax: +90-312-363-6213; Email: idilman@dialup.ankara.edu.tr Reactivation of hepatitis B virus (HBV) is […]


Abacavir and lamivudine-Epzicom
  by hijadoo
U.S. BRAND NAMES — Epzicomâ„¢PHARMACOLOGIC CATEGORY Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)DOSING: ADULTS — HIV: Oral: One tablet (abacavir 600 mg and lamivudine 300 mg) once dailyDOSING: RENAL […]


Abacavir, lamivudine, and zidovudine-Trizivir
  by hijadoo
U.S. BRAND NAMES — Trizivir®PHARMACOLOGIC CATEGORY Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)DOSING: ADULTS — HIV treatment: Oral: 1 tablet twice daily. Note: Not recommended for patients <40 kg.DOSING: […]


abacavir
  by kanlayanee
Abacavir (ABC) is the most powerful nucleoside analog reverse transcriptase inhibitor (NARTI) used to treat HIV and AIDS. Viral strains that are resistant to zidovudine (AZT) […]


abacavir: Ziagen
  by kanlayanee
[caption id="" align="alignleft" width="250" caption="Abacavir (Ziagen) 300mg"][/caption] Antiviral drug Abacavir (ABC) is the most powerful nucleoside analog reverse transcriptase inhibitor (NARTI) used to treat HIV and AIDS. Viral […]


HIV/AIDS Update - Tentative approval of stavudine, lamivudine and nevirapine fixed dose combination tablets
  by neurologist
On February 27, 2009, FDA granted tentative approval to stavudine, lamivudine and nevirapine fixed dose  combination tablets,30mg/150mg/200mg &  40mg/150mg/200mg,made by Pharmacare Limited t/a Aspen Pharmacare of South Africa.  […]


HIV/AIDS Update - Tenative approval of lamivudine/zidovudine fixed dose combination tablets plus nev
  by neurologist
body {background-color: white; font-family: "Tahoma"; font-size: x-small;direction: rtl}On May 7, 2009, using expedited review procedures developed to support the President's Emergency Program For AIDS Relief (PEPFAR), FDA granted tentative […]


Cool drug words (HIV/virology edition)
  by redpenmedjen
My agency works with a company that manufactures tests to determine if a patient's strain of HIV will be susceptible to certain drugs (antivirals). The drug names mentioned […]


Epivir [lamivudine] is a particular anti-viral dru …
  by rathindey
Epivir [lamivudine] is a particular anti-viral drug that helps in preventing the growth and multiplication of the cells suffering from the Human immunodeficiency virus […]



Other reviews about Lamivudine on web:

Lamivudine (2',3'-dideoxy-3'-thia cytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand ... Lamivudine - Wikipedia, the free encyclopedia


Learn about the prescription medication Epivir (Lamivudine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Epivir (Lamivudine) Drug Information: Uses, Side Effects, Drug ...


All about Lamivudine Tablets. View complete and up to date Lamivudine information - part of the Drugs.com trusted medication database. Lamivudine Tablets Facts and Comparisons at Drugs.com


Approval: FDA approval of lamivudine was granted in 1995 for adult and pediatric use. Initial approval (for use in combination with zidovudine) was based on increases in CD4 T ... Lamivudine (Epivir)


lamivudine n 3TC trade name: Epivir; drug class: antiviral, nucleoside analog; action: inhibition of HIV reverse transcriptase; also inhibits RNA- and Lamivudine: Definition from Answers.com


Physician reviewed lamivudine patient information - includes lamivudine description, dosage and directions. lamivudine medical facts from Drugs.com


Brand Name: Epivir: Other Name(s): 3TC, Epivir-HBV, Lamivudina: Drug Class: Nucleoside Reverse Transcriptase Inhibitors: Lamivudine, also known as Epivir or 3TC, is a type of medicine ... AIDSinfo - HIV/AIDS Drug Information - Lamivudine


Consumer information about the medication LAMIVUDINE ORAL TABLETS (Epivir), includes side effects, drug interactions, recommended dosages, and storage information. Read more about ... LAMIVUDINE ORAL TABLETS (Epivir) side effects, medical uses, and ...


Lamivudine, when used alone or in combination with other antiviral medications, can cause serious damage to the liver and a condition called lactic acidosis. Lamivudine: MedlinePlus Drug Information


lamivudine /la·miv·u·dine/ (lah-miv´u-dēn) a nucleoside analogue that inhibits reverse transcriptase, used as an antiviral agent in the treatment of chronic hepatitis B and, in ... lamivudine - definition of lamivudine in the Medical dictionary ...





Featured Reviews

Reviews Zolmitriptan

Zomig Drug Description ZOMIG® (zolmitriptan) Tablets ZOMIG-ZMT® (zolmitriptan) Orally Disintegrating Tablets DRUG DESCRIPTION What are the possible side effects of nasal zolmitriptan (Zomig)? Get emergency medical help...
Read More  |  Review This
Reviews Pipracil

Pipracil Drug Description PIPRACIL® (piperacillin for injection) For Intravenous and Intramuscular Use To reduce the development of drug-resistant bacteria and maintain the effectiveness of PIPRACIL and other antibacterial drugs,...
Read More  |  Review This
Reviews BiCNU

BiCNU Drug Description BiCNU (carmustine) For Injection WARNINGS BiCNU (carmustine for injection) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents....
Read More  |  Review This
Reviews Propine

Propine Drug Description PROPINE® (dipivefrin hydrochloride) Ophthalmic Solution, USP 0.1% sterile DRUG DESCRIPTION What are the possible side effects of dipivefrin ophthalmic (Propine)? Stop using dipivefrin and get emergency...
Read More  |  Review This
Reviews Memantine Hydrochloride Extended Release Capsules

Namenda XR Drug Description NAMENDA XR (memantine hydrochloride) Extended Release Capsules DRUG DESCRIPTION NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....